(Q37898511)

25 August 2017

1 reference

title

The sympathetic nervous system and blood pressure in humans: implications for hypertension (English)

1 reference

25 August 2017

arterial hypertension

0 references

0 references

2

J F R Paton

1 reference

25 August 2017

1

J P Fisher

1 reference

25 August 2017

7 July 2011

1 reference

Journal of Human Hypertension

25 August 2017

1 reference

25 August 2017

26

1 reference

25 August 2017

8

1 reference

25 August 2017

463-475

1 reference

https://scigraph.springernature.com/pub.10.1038/jhh.2011.66

25 August 2017

0 references

cites work

Essential Hypertension : Part I: Definition and Etiology

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Point: Chronic Activation of the Sympathetic Nervous System is the Dominant Contributor to Systemic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympathetic neural mechanisms in white-coat hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Relationship between central sympathetic activity and stages of human hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympathectomy in the treatment of hypertension; review of 122 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Central sympathetic overactivity: maladies and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Reactive oxygen species in the neuropathogenesis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Plasma catecholamines and essential hypertension. An analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

How to assess sympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

A sympathetic view of the sympathetic nervous system and human blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Arterial baroreceptor reflex control of sympathetic nerve activity in the spontaneously hypertensive rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Do changes in the coupling between respiratory and sympathetic activities contribute to neurogenic hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Global myocardial hypertrophy in conscious dogs with chronic elevation of plasma norepinephrine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Basis for Recurring Ventricular Fibrillation in the Absence of Coronary Heart Disease and Its Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Harvey Cushing and the regulation of blood pressure in giraffe, rat and man: introducing 'Cushing's mechanism'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Translational medicine: the antihypertensive effect of renal denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Increased muscle sympathetic nerve activity predicts mortality in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympatholytic therapy in primary hypertension: a user friendly role for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Exercise training and sympathetic regulation in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

The sympathetic nervous system and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympathetic nerve activity is decreased during device-guided slow breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Nonpharmacologic treatment of resistant hypertensives by device-guided slow breathing exercises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Effect of device-guided breathing exercises on blood pressure in patients with hypertension: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Accelerating the pulse of cardiovascular R&D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

New therapeutic approaches to resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Renal sympathetic-nerve ablation for uncontrolled hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Circulatory effects of electrical stimulation of the carotid sinus nerves in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Unloading arterial baroreceptors causes neurogenic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sustained reduction of hypertension by deep brain stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Deep brain stimulation relieves refractory hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Viscerotopic organization of neurons subserving hypotensive reactions within the midbrain periaqueductal grey: a correlative functional and anatomical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Reconceptualizing support systems for persons with challenging behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Oxidative stress contributes to renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

The circumventricular organs and the central actions of angiotensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Regulation of T-cell function by endogenously produced angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

C-reactive protein and the risk of developing hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Association of F11 receptor gene polymorphisms with central obesity and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Brain microglial cytokines in neurogenic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

IL-6 microinjected in the nucleus tractus solitarii attenuates cardiac baroreceptor reflex function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Gene expression profiles of major cytokines in the nucleus tractus solitarii of the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Specific inflammatory condition in nucleus tractus solitarii of the SHR: novel insight for neurogenic hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Central nervous system administration of interleukin-6 produces splenic sympathoexcitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Down-regulation of chemokine Ccl5 gene expression in the NTS of SHR may be pro-hypertensive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Specific actions of cyanide on membrane potential and voltage-gated ion currents in rostral ventrolateral medulla neurons in rat brainstem slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Ischaemia-induced sympathoexcitation in spinalyzed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Relationship of neurovascular compression to central sympathetic discharge and essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Arterial hypertension and neurovascular compression at the ventrolateral medulla. A comparative microanatomical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Hypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

Physiological aspects of primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Role of the sympathetic nervous system in human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Sympathetic and parasympathetic influence on blood pressure and heart rate variability in Wistar-Kyoto and spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Regional sympathetic activity in pre-hypertensive phase of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Sympathoadrenal system is critical for structural changes in genetic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Neural Activity and Ventricular Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Effects of prehypertension on arterial stiffness and wave reflections

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Sympathetic modulation of radial artery compliance in congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Increased oxidative stress impairs endothelial modulation of contractions in arteries from spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Noradrenergic Vascular Hyper-Responsiveness in Human Hypertension Is Dependent on Oxygen Free Radical Impairment of Nitric Oxide Activity

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Angiotensin II blood-levels in human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Sympathetic outflow to muscles during treatment of hypertension with metoprolol

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Restraining influence of A2 neurons in chronic control of arterial pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Concerning postexercise hypotension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Exercise training restores baroreflex sensitivity in never-treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Weight loss improves neurovascular and muscle metaboreflex control in obesity

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Regular slow-breathing exercise effects on blood pressure and breathing patterns at rest

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

TREATMENT OF HYPERTENSION WITH AN IMPLANTABLE ELECTRONIC DEVICE

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Characteristics of brachiocephalic and carotid sinus baroreceptors with non-medullated afferents in rabbit

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Functional organization of central pathways regulating the cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Elevated vertebrobasilar artery resistance in neonatal spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.66

7 January 2021

Identifiers

DOI

10.1038/JHH.2011.66

1 reference

PubMed ID

21734720

Dimensions Publication ID

25 August 2017

0 references

1 reference

PubMed ID

21734720